Is heptaminol a (major) metabolite of octodrine? / Josef Dib, Christina Bosse, Maria Tsivou, Anna‐M. Glatt, Thomas Geisendorfer, Hans Geyer, Günter Gmeiner, Gerd Sigmund, Mario Thevis. - (Drug Testing and Analysis 11 (2019) 11-12 (November-December); p. 1761-1763). - Special Issue: 37th Cologne workshop: Advances in sports drug testing.
- PMID: 31763761.
- DOI: 10.1002/dta.2737
In 2018, two adverse analytical findings (AAFs) were reported concerning the specified stimulant heptaminol in the context of routine doping controls by a World Anti‐Doping Agency (WADA)‐accredited laboratory. In the course of inquests into these cases, both affected athletes declared the use of nutritional supplements, advertised as fat‐burner and pre‐workout products. These supplements did not list heptaminol as an ingredient on the respective product labels, and chromatographic‐mass spectrometric analyses confirmed the absence of heptaminol. However, both supplements declared the ingredient 2‐aminoisoheptane, a frequently observed (whilst incorrect) synonym for octodrine.